Brian L. Selby - Net Worth and Insider Trading

Brian L. Selby Net Worth

The estimated net worth of Brian L. Selby is at least $0 dollars as of 2024-04-25. Brian L. Selby is the VP, Finance of ARCA biopharma Inc and owns about 0 shares of ARCA biopharma Inc (ABIO) stock worth over $0. Details can be seen in Brian L. Selby's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian L. Selby has not made any transactions after 2018-04-02 and currently still holds the listed stock(s).

Transaction Summary of Brian L. Selby

Brian L. Selby Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian L. Selby owns 1 companies in total, including ARCA biopharma Inc (ABIO) .

Click here to see the complete history of Brian L. Selby’s form 4 insider trades.

Insider Ownership Summary of Brian L. Selby

Ticker	Comapny	Transaction Date	Type of Owner
ABIO	ARCA biopharma Inc	2018-04-02	VP & Finance

Brian L. Selby Latest Holdings Summary

Brian L. Selby currently owns a total of 1 stock. Brian L. Selby owns 0 shares of ARCA biopharma Inc (ABIO) as of April 2, 2018, with a value of $0.

Latest Holdings of Brian L. Selby

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ABIO	ARCA biopharma Inc	2018-04-02	0	3.50	0

Holding Weightings of Brian L. Selby

Brian L. Selby Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian L. Selby has made a total of 0 transactions in ARCA biopharma Inc (ABIO) over the past 5 years. The most-recent trade in ARCA biopharma Inc is the sale of 62 shares on April 2, 2018, which brought Brian L. Selby around $557.

Insider Trading History of Brian L. Selby

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian L. Selby Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brian L. Selby Ownership Network

Ownership Network List of Brian L. Selby

No Data

Ownership Network Relation of Brian L. Selby

Brian L. Selby Owned Company Details

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Brian L. Selby is the VP & Finance of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

Brian L. Selby Mailing Address

Above is the net worth, insider trading, and ownership report for Brian L. Selby. You might contact Brian L. Selby via mailing address: 11080 Circlepoint Road, Suite 140, Westminster Co 80020.

Discussions on Brian L. Selby

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.